Recent Advances in Alzheimer Dementia Biomarkers
Michael Elnemais Fawzy;
Abstract
Summary
Alzheimer’s disease is a progressive disorder that negatively impacts cognitive, behavioral, and functional abilities. As AD progresses, cognitive impairment, functional losses, and Neuropsychiatric symptoms (NPS) progress and accelerate. In Mild
Alzheimer’s disease is a progressive disorder that negatively impacts cognitive, behavioral, and functional abilities. As AD progresses, cognitive impairment, functional losses, and Neuropsychiatric symptoms (NPS) progress and accelerate. In Mild
Other data
| Title | Recent Advances in Alzheimer Dementia Biomarkers | Other Titles | أحدث التطورات في المؤشرات الحيوية التشخيصية لمرض الزهايمر | Authors | Michael Elnemais Fawzy | Keywords | Recent Advances in Alzheimer Dementia Biomarkers | Issue Date | 2012 | Description | Summary Alzheimer’s disease is a progressive disorder that negatively impacts cognitive, behavioral, and functional abilities. As AD progresses, cognitive impairment, functional losses, and Neuropsychiatric symptoms (NPS) progress and accelerate. In Mild |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 116882p7219.pdf | 327.19 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.